Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Serina Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 35 | 1 | 32 | −2 |
| Shares | 4.82M | 300 | 4.75M | −79.0K (−1.6%) |
| Value | $7.48M | $0 | $4.46M | −$3.02M (−40.4%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Serina Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 40,537 | $38.0K | 0.00% |
| Corsicana & Co. | 1,000 | $1.00K | 0.00% |
| Community Bank, N.A. | 50 | $0 | 0.00% |
Sold out (5)
Institutions that held Serina Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Renaissance Technologies LLC | 75,059 | $116.0K |
| Barclays PLC | 41,100 | $64.0K |
| Credential Qtrade Securities Inc. | 292 | $452 |
| Citigroup Inc | 80 | $0 |
| Iron Horse Wealth Management, LLC | 11 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Serina Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| CWM, LLC | 300 | $0 |